Docstoc

chordoma global clinical trials

Document Sample
chordoma global clinical trials Powered By Docstoc
					Chordoma Global Clinical Trials Review, H1, 2012
Published: February 2012                         No. of Pages: 52                       Price: US$1000




GlobalData's clinical trial report, “Chordoma Global Clinical Trials Review, H1, 2012" provides data on the
Chordoma clinical trial scenario. This report provides elemental information and data relating to the
clinical trials on Chordoma. It includes an overview of the trial numbers and their recruitment status as per
the site of trial conduction across the globe. The databook offers a preliminary coverage of disease
clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining
to the number of trials for the key drugs for treating Chordoma. This report is built using data and
information sourced from proprietary databases, primary and secondary research and in-house analysis
by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of
data for the indicated disease.

Scope

       Data on the number of clinical trials conducted in North America, South and Central America,
        Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along
        with the clinical trial scenario in BRIC nations
       Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor
        type
       Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

       Understand the dynamics of a particular indication in a condensed manner
       Abridged view of the performance of the trials in terms of their status, recruitment, location,
        sponsor type and many more
       Obtain discontinued trial listing for trials across the globe
       Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Chordoma Clinical Trials

        Table of Contents

       Table of Contents 2
        List of Tables 3
        List of Figures 3
       Introduction 4
        Chordoma 4
        Report Guidance 4
        Clinical Trials by Region 5
        Clinical Trials by Country 6
        Top Countries Contributing to Clinical Trials in Asia-Pacific 8
        Top Five Countries Contributing to Clinical Trials in Europe 9
        Top Countries Contributing to Clinical Trials in North America 10
        Top Countries Contributing to Clinical Trials in Central and South America 11
    Clinical Trials by G7 Nations 12
    Clinical Trials in G7 Nations by Trial Status 13
    Clinical Trials by Phase 14
    In Progress Trials by Phase 15
    Clinical Trials by Trial Status 16
    Unaccomplished Trials of Chordoma 17
    Subjects Recruited Over a Period of Time 18
    Prominent Sponsors 19
    Prominent Drug Comparison 21
    Clinical Trial Profiles 22
    Clinical Trial Overview of Top Companies 22
    Novartis AG 22
    Clinical Trial Overview of Novartis AG 22
    Clinical Trial Overview of Top Universities / Institutes / Hospitals 23
    Massachusetts General Hospital 23
    Clinical Trial Overview of Massachusetts General Hospital 23
    Sarcoma Alliance for Research through Collaboration 24
    Clinical Trial Overview of Sarcoma Alliance for Research through Collaboration 24
    St. John's Mercy Health Care 25
    Clinical Trial Overview of St. John's Mercy Health Care 25
    University of Virginia 26
    Clinical Trial Overview of University of Virginia 26
    The University of Texas M. D. Anderson Cancer Center 27
    Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 27
    Five Key Clinical Profiles 28
   Appendix 49
    Abbreviations 49
    Definitions 49
    Research Methodology 50
    Secondary Research 50
    About GlobalData 51
    Contact Us 51
    Disclaimer 51
    Source 52
   List of Tables
   Chordoma Therapeutics Market, Global, Clinical Trials by Zone, 2012* 5
    Chordoma Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 6
    Chordoma Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 7
    Chordoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2012* 8
    Chordoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 9
    Chordoma Therapeutics Clinical Trials, North America, Top Countries, 2012* 10
    Chordoma Therapeutics Clinical Trials, Central and South America, Top Countries, 2012* 11
    Chordoma Therapeutics Clinical Trials, G7 Countries, 2012* 12
    Chordoma Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 13
    Chordoma Therapeutics Market, Global, Clinical Trials by Phase, 2012* 14
    Chordoma Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 15
    Chordoma Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 16
    Chordoma Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 17
    Chordoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 18
    Chordoma Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 20
    Chordoma Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 21
    Chordoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012* 22
    Chordoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General
    Hospital, 2012* 23
    Chordoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sarcoma Alliance for
    Research through Collaboration, 2012* 24
    Chordoma Therapeutics Clinical Trials Market, Global, Clinical Trials by St. John's Mercy Health
    Care, 2012* 25
    Chordoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Virginia,
    2012* 26
    Chordoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas
    M. D. Anderson Cancer Center, 2012* 27
   List of Figures
   Chordoma Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 5
    Chordoma Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 6
    Chordoma Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 7
    Chordoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2012* 8
    Chordoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 9
    Chordoma Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 10
    Chordoma Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2012* 11
    Chordoma Therapeutics Clinical Trials, G7 Countries (%), 2012* 12
    Chordoma Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 13
    Chordoma Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 14
    Chordoma Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 15
    Chordoma Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 16
    Chordoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 18
    Chordoma Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 19
    Chordoma Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 21
    GlobalData Methodology 50

				
DOCUMENT INFO
Shared By:
Categories:
Stats:
views:5
posted:2/24/2012
language:Latin
pages:3
Description: GlobalData's clinical trial report, “Chordoma Global Clinical Trials Review, H1, 2012" provides data on the Chordoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chordoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Chordoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.